Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Leber » Leberzirrhose 24. Februar 2026
Suchen
Gastroplattform
Leberzirrhose
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1900  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 37992  
   
A Novel Prognostic Score for 1-Year Adverse Outcomes in Non-ACLF Cirrhotic Patients After Discharge: A Multicenter Prospective Cohort Study.
J Dig Dis
Bian YX, Zhang X, Wang XB, Zheng X, Tan WT, Jiang XH, Huang Y, Meng ZJ, Gao YH, Qian ZP, Liu F, Lu XB, Shi Y, Zheng YB, He YL, Wei JY, Ji PX, He K, Abuduaini A, Lu YW, Qiao L, Li H, Chinese (Acute on) Chronic Liver Failure Consortium (Ch.
PMID: 41731735 [PubMed - as supplied by publisher]


Early Prediction of Hepatic Decompensation in Cirrhosis Using Optimised XGBoost Models at the Initial Outpatient Hepatology Visit.
Liver Int
Grubert Van Iderstine M, Perez S, Jackson GS, Szun T, Stephanson C, Weisshaar M, Minuk GY, Faisal N.
PMID: 41731684 [PubMed - indexed for MEDLINE]


Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis.
Hepatol Commun
Singal AG, Jin Q, Marrero J, Parikh ND, Lok AS, Lopez C, Page-Lester S, Roberts LR, Reddy R, Luster M, Khaderi S, Asrani SK, El-Serag HB, Kanwal F, Feng Z, Tayob N.
PMID: 41730232 [PubMed - indexed for MEDLINE]


SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.
JAMA Netw Open
Chung MC, Yu TM, Wu LY, Wu MJ, Shieh JJ, Chung CJ.
PMID: 41729519 [PubMed - indexed for MEDLINE]


Evaluation of spleen stiffness and liver stiffness as non-invasive predictors of esophageal varices in patients with cirrhosis of the liver.
Indian J Gastroenterol
Verma A, Giri S, Sahu SK, Priyadarshini S, Praharaj DL, Mallick B, Nath P, Panigrahi SC, Sahu MK, Anand AC, Chawla YK, Acharya SK.
PMID: 41729455 [PubMed - as supplied by publisher]


FCFNets: A Factual and Counterfactual Learning Framework for Enhanced Hepatic Fibrosis Prediction in Young Adults with T2D.
AMIA Annu Symp Proc
Yang Q, Sharma A, Calin D, de Crecy C, Inampudi R, Yin R.
PMID: 41726453 [PubMed - indexed for MEDLINE]


A retrospective study on the use of albumin in the management of complications of decompensated cirrhosis from a major teaching hospital in Canada.
Can Liver J
Kilany M, Tiwari N, Wong F.
PMID: 41725792 [PubMed]


Prognostic value of blood urea nitrogen to albumin ratio in critically ill cirrhotic patients with ascites.
Sci Rep
Duan Y, Sui W, Cai Z, Xia Y, Li J, Fu J.
PMID: 41723285 [PubMed - as supplied by publisher]


Association between specialized nutrition support and 90-day mortality relative to standard of care in malnourished adults with decompensated cirrhosis: A retrospective cohort study.
JPEN J Parenter Enteral Nutr
Hupa-Breier KL, Buttler L, Seipt C, Markowski A, Griemsmann M, Tergast TL, Kaufmann B, Rieland H, Wedemeyer H, Maasoumy B, Schneider A.
PMID: 41720466 [PubMed - as supplied by publisher]


Letter to Editor regarding: Real-world outcomes in patients with cirrhosis undergoing cholecystectomy: a population-based study.
J Gastrointest Surg
Liu Z.
PMID: 41720294 [PubMed - as supplied by publisher]


Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose study.
Lancet Gastroenterol Hepatol
Uschner FE, McCoy M, Tyc O, Gu W, Ferstl P, Brol MJ, Masseli J, Peiffer KH, Finkelmeier F, Zeuzem S, Biguenet S, Staufer K, Kabbaj M, Trebicka J.
PMID: 41720142 [PubMed - as supplied by publisher]


Acromegaly presenting with normal insulin-like growth factor-1 levels in a patient with advanced liver cirrhosis.
BMJ Case Rep
Kilcoyne C, Burke K, O'Reilly MW, Iqbal M, Sherlock M.
PMID: 41713883 [PubMed - indexed for MEDLINE]


Predictive factors of significant fibrosis in metabolic dysfunction-associated steatotic liver disease.
Tunis Med
Mensi A, Krifa N, Bel Haj Mabrouk E, Trad N, Ayadi S, Debbeche R.
PMID: 41712809 [PubMed - indexed for MEDLINE]


Mapping fibrosis in colorectal liver metastases (CRLM) with gadobenate dimeglumine-enhanced MRI: prognostic implications and imaging biomarkers.
Int J Colorectal Dis
Morawska I, Pasicz K, Cieszanowski A.
PMID: 41711984 [PubMed - indexed for MEDLINE]


Diabetes and risk of significant fibrosis in adults with HIV and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
J Antimicrob Chemother
Han WM, Apornpong T, Chuaypen N, Aung TPP, Amornritvanich P, Hiranburana N, Lwin HMS, Hiransuthikul A, Kerr S, Tangkijvanich P, Avihingsanon A.
PMID: 41710964 [PubMed - indexed for MEDLINE]


Global epidemiology of bacterial infections in patients with cirrhosis: a systematic review and meta-analysis.
J Hepatol
Cai J, Yip TC, Wong GL, Zhang Y, Chan PP, Liu X, Zhang T, Fong AT, Chi Z, Lai KM, Lau KC, Ching SL, Garcia-Tsao G, Abraldes JG, Lui GC, Wong VW, Sun J, Lai JC.
PMID: 41707941 [PubMed - as supplied by publisher]


HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis.
Front Immunol
Martín-Escolano R, Fernández-Rodríguez A, Tarancon-Diez L, Berenguer J, Codina H, Amigot-Sánchez R, González-García J, Hontañón V, Pérez-Latorre L, Ibañez-Samaniego L, Llop-Herrera E, Olveira A, Díaz L, Martínez I, Jiménez-Sousa MÁ, Resino S.
PMID: 41705254 [PubMed - indexed for MEDLINE]


Compression pressure of the external jugular vein for the assessment of intravascular volume status in decompensated cirrhosis: A pilot study.
JHEP Rep
Segna D, Messerli B, Baumann U, Bosch J, Berzigotti A.
PMID: 41704424 [PubMed]


Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world data.
J Med Econ
Porta C, Pradelli L, Cirotto G, Majorini MT, Garay OU, Calvaruso V, Fasano T, Napoli L, Foschi FG, Lampertico P.
PMID: 41701165 [PubMed - indexed for MEDLINE]


Ion channel gene signature for diagnosis and antifibrotic therapy in liver fibrosis.
J Transl Med
Li Y, Shen D, Qin F, Chen D, Li J.
PMID: 41699670 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 37992    Seite 1 von 1900  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1